Industries › Healthcare › Pharmaceutical Preparations
Pharmaceutical Preparations
The 511 US-listed Pharmaceutical Preparations companies we cover, ranked by market cap. Updated
The largest Pharmaceutical Preparations companies by market cap: Lilly (Eli), Johnson & Johnson, Beone Medicines Ltd., AbbVie, Merck. Together, the 500 companies we cover report $665.1B in combined trailing-twelve-month revenue — the sum of covered companies' reported revenue, not an industry market-size estimate.
Pharmaceutical Preparations heatmap
Tile size is market cap; color is the latest daily change.
Technical signals in Pharmaceutical Preparations
Chart conditions currently in force among Pharmaceutical Preparations stocks — each opens the screener filtered to Pharmaceutical Preparations + that signal.
Golden Cross Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks whose 50-day moving average has just crossed above the 200-day — a widely-watched long-term trend signal. A live technical scan, refreshed daily — informational, not advice.
Golden Cross screener →New 52-Week High Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks that just printed a fresh 52-week high. A live technical scan, refreshed daily — informational, not advice.
52-week-high screener →Oversold Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks with a 14-day RSI below 30, the level chartists call oversold. A live technical scan, refreshed daily — informational, not advice.
Oversold screener →Overbought Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks with a 14-day RSI above 70 (overbought territory). A live technical scan, refreshed daily — informational, not advice.
Overbought screener →RSI Bounce Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks where the 14-day RSI has just turned up out of oversold. A live technical scan, refreshed daily — informational, not advice.
RSI-bounce screener →Near 52-Week High Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks trading within 10% of their 52-week high. A live technical scan, refreshed daily — informational, not advice.
52-week-high screener →Companies
| LLY | Lilly (Eli) | 1409.39 | -0.12% | $1.33T |
| JNJ | Johnson & Johnson | 266.17 | -1.76% | $640.8B |
| ONC | Beone Medicines Ltd. | 354.91 | -1.72% | $524.6B |
| ABBV | AbbVie | 285.02 | -1.30% | $503.8B |
| MRK | Merck | 144.67 | -2.57% | $356.9B |
| ABT | Abbott Laboratories | 109.43 | -0.78% | $190.6B |
| PFE | Pfizer | 30.04 | -2.18% | $171.2B |
| VRTX | Vertex Pharmaceuticals | 531.19 | -6.81% | $134.7B |
| BMY | Bristol Myers Squibb | 61.71 | -2.09% | $126.1B |
| REGN | Regeneron Pharmaceuticals | 973.80 | +1.30% | $100.7B |
| TEVA | Teva Pharmaceutical Industries Ltd | 41.90 | +3.00% | $48.9B |
| ZTS | Zoetis | 83.02 | -0.18% | $34.3B |
| RPRX | Royalty Pharma Plc | 66.35 | -0.26% | $29.5B |
| ROIV | Roivant Sciences Ltd. | 36.06 | +0.47% | $26.0B |
| UTHR | United Therapeutics Corp | 601.74 | +0.95% | $25.8B |
| ZLAB | Zai Lab Ltd | 21.97 | +1.41% | $24.7B |
| INSM | Insmed Incorporated | 104.46 | -4.45% | $22.9B |
| VTRS | Viatris | 18.94 | +1.39% | $21.8B |
| ALNY | Alnylam Pharmaceuticals | 159.85 | +1.21% | $21.4B |
| JAZZ | Jazz Pharmaceuticals Plc | 229.93 | +7.21% | $14.8B |
| BBIO | Bridgebio Pharma, Inc. | 74.00 | -1.32% | $14.4B |
| SMMT | Summit Therapeutics Inc. | 15.80 | +6.04% | $12.6B |
| ELAN | Elanco Animal Health Inc | 24.58 | +2.06% | $12.3B |
| BMRN | Biomarin Pharmaceutical Inc | 55.69 | -3.10% | $10.8B |
| SYRE | Spyre Therapeutics, Inc. | 99.33 | +3.99% | $9.4B |
| TGTX | Tg Therapeutics, Inc. | 60.77 | +1.27% | $9.3B |
| MDGL | Madrigal Pharmaceuticals, Inc. | 396.06 | -8.07% | $9.2B |
| PTGX | Protagonist Therapeutics, Inc | 140.44 | +0.77% | $9.1B |
| CYTK | Cytokinetics Inc | 62.35 | +0.38% | $8.7B |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 59.52 | -0.07% | $8.4B |
| CORT | Corcept Therapeutics Inc | 74.95 | -6.92% | $8.2B |
| PRAX | Praxis Precision Medicines, Inc. | 280.64 | +2.64% | $7.8B |
| ALKS | Alkermes Plc. | 45.66 | +1.81% | $7.7B |
| AXSM | Axsome Therapeutics, Inc. | 139.54 | +2.69% | $7.3B |
| KNSA | Kiniksa Pharmaceuticals International, Plc | 93.15 | +2.69% | $7.2B |
| IONS | Ionis Pharmaceuticals Inc | 40.42 | -1.95% | $6.7B |
| ORKA | Oruka Therapeutics, Inc. | 99.64 | +4.40% | $6.6B |
| AMRX | Amneal Pharmaceuticals, Inc. | 20.23 | -1.03% | $6.5B |
| LGND | Ligand Pharmaceuticals Inc | 314.00 | +2.41% | $6.3B |
| RYTM | Rhythm Pharmaceuticals, Inc. | 86.26 | -7.83% | $6.0B |
| PTCT | Ptc Therapeutics, Inc. | 68.18 | +12.06% | $5.7B |
| MIRM | Mirum Pharmaceuticals, Inc. | 87.01 | +1.39% | $5.7B |
| MANE | Veradermics, Inc | 133.38 | +2.97% | $5.6B |
| COGT | Cogent Biosciences, Inc. | 31.06 | +4.47% | $5.4B |
| ERAS | Erasca, Inc. | 14.65 | +4.42% | $5.1B |
| TVTX | Travere Therapeutics, Inc. | 49.47 | +2.75% | $4.7B |
| DNTH | Dianthus Therapeutics, Inc. /De/ | 82.81 | +0.69% | $4.6B |
| GPCR | Structure Therapeutics Inc. | 20.35 | -0.51% | $4.4B |
| INDV | Indivior Pharmaceuticals, Inc. | 36.26 | +2.43% | $4.3B |
| EWTX | Edgewise Therapeutics, Inc. | 37.67 | -1.28% | $4.1B |
| ARQT | Arcutis Biotherapeutics, Inc. | 32.02 | +2.46% | $4.0B |
| TNGX | Tango Therapeutics, Inc. | 23.18 | +6.57% | $3.9B |
| LQDA | Liquidia Corp | 42.21 | +0.84% | $3.8B |
| ABCL | Abcellera Biologics Inc. | 12.18 | +9.49% | $3.7B |
| XENE | Xenon Pharmaceuticals Inc. | 38.23 | +1.68% | $3.7B |
| OGN | Organon & Co. | 13.85 | +0.18% | $3.6B |
| PBLS | Parabilis Medicines, Inc. | 29.28 | +7.21% | $3.6B |
| ACAD | Acadia Pharmaceuticals Inc | 20.59 | +0.59% | $3.5B |
| DYN | Dyne Therapeutics, Inc. | 18.05 | +4.27% | $3.4B |
| VKTX | Viking Therapeutics, Inc. | 26.11 | -2.68% | $3.3B |
| ELVN | Enliven Therapeutics, Inc. | 44.84 | +0.50% | $3.3B |
| AMLX | Amylyx Pharmaceuticals, Inc. | 29.23 | +4.23% | $3.3B |
| IRON | Disc Medicine, Inc. | 81.17 | +3.30% | $3.1B |
| BHC | Bausch Health Companies Inc. | 8.13 | +1.25% | $3.0B |
| IDYA | Ideaya Biosciences, Inc. | 31.32 | -0.85% | $3.0B |
| VRDN | Viridian Therapeutics, Inc.De | 25.13 | -0.59% | $2.8B |
| SLN | Silence Therapeutics Plc | 19.79 | +0.13% | $2.8B |
| MBX | Mbx Biosciences, Inc. | 55.05 | +1.31% | $2.7B |
| RCUS | Arcus Biosciences, Inc. | 18.92 | +5.99% | $2.4B |
| NAMS | Newamsterdam Pharma Co N.V. | 19.88 | +1.53% | $2.4B |
| BHVN | Biohaven Ltd. | 15.62 | +3.17% | $2.4B |
| PBH | Prestige Consumer Healthcare Inc. | 49.52 | -0.47% | $2.3B |
| IMNM | Immunome Inc. | 20.32 | +3.73% | $2.3B |
| XNCR | Xencor Inc | 30.64 | +3.34% | $2.3B |
| PHVS | Pharvaris N.V. | 34.79 | +3.84% | $2.3B |
| AUPH | Aurinia Pharmaceuticals Inc. | 16.57 | +2.63% | $2.2B |
| VERA | Vera Therapeutics, Inc. | 30.73 | +1.54% | $2.2B |
| PVLA | Palvella Therapeutics, Inc. | 153.00 | +4.39% | $2.2B |
| PRGO | Perrigo Co Plc | 15.68 | -0.70% | $2.2B |
| HRMY | Harmony Biosciences Holdings, Inc. | 37.00 | -2.53% | $2.2B |
| ZYME | Zymeworks Inc. | 30.13 | +3.90% | $2.1B |
| SEPN | Septerna, Inc. | 43.74 | +1.13% | $2.0B |
| SDGR | Schrodinger, Inc. | 27.18 | +3.80% | $2.0B |
| TRVI | Trevi Therapeutics, Inc. | 13.87 | +1.72% | $2.0B |
| SRPT | Sarepta Therapeutics, Inc. | 18.54 | +1.26% | $2.0B |
| TRAX | First Tracks Biotherapeutics, Inc. | 46.38 | +2.94% | $1.9B |
| BRVE | Braveheart Bio, Inc. | 21.41 | +1.69% | $1.9B |
| XERS | Xeris Biopharma Holdings, Inc. | 10.36 | +2.07% | $1.9B |
| PGEN | Precigen, Inc. | 5.25 | +2.24% | $1.9B |
| AGIO | Agios Pharmaceuticals, Inc. | 31.20 | +4.26% | $1.9B |
| NRIX | Nurix Therapeutics, Inc. | 17.00 | -33.84% | $1.9B |
| ZBIO | Zenas Biopharma, Inc. | 28.36 | +2.81% | $1.8B |
| SLS | Sellas Life Sciences Group, Inc. | 8.87 | +3.74% | $1.8B |
| GENB | Generate Biomedicines, Inc. | 13.86 | +4.80% | $1.8B |
| STOK | Stoke Therapeutics, Inc. | 27.00 | +2.02% | $1.8B |
| URGN | Urogen Pharma Ltd. | 34.43 | +0.15% | $1.7B |
| NUVB | Nuvation Bio Inc. | 4.70 | +2.40% | $1.7B |
| SUPN | Supernus Pharmaceuticals, Inc. | 28.19 | -32.80% | $1.6B |
| KLRA | Kailera Therapeutics, Inc. | 12.58 | +3.50% | $1.6B |
| PAHC | Phibro Animal Health Corp | 37.64 | -2.81% | $1.5B |
Frequently asked questions
How many Pharmaceutical Preparations companies are there?
We cover 511 US-listed Pharmaceutical Preparations companies as of 2026-11-04, refreshed every trading day.
Who are the largest Pharmaceutical Preparations companies?
By market cap, the largest Pharmaceutical Preparations companies we cover are Lilly (Eli) (LLY), Johnson & Johnson (JNJ), Beone Medicines Ltd. (ONC).
What is the combined market cap of the Pharmaceutical Preparations industry?
The 511 US-listed Pharmaceutical Preparations companies we cover have a combined market capitalization of $4.79 trillion as of 2026-11-04.
What is the total revenue of the Pharmaceutical Preparations industry?
The combined trailing-twelve-month revenue of the US-listed Pharmaceutical Preparations companies we cover is $665.1 billion. This is the sum of covered companies' reported revenue — not an industry market-size estimate.
What is the average dividend yield of Pharmaceutical Preparations companies?
The cap-weighted average dividend yield of the Pharmaceutical Preparations stocks we cover is 1.85%.
Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices) · combined figures are sums/averages of the US-listed companies we cover. Informational only — not financial advice.